Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
HIBISCUS MED from Lede, company number BE1017485359, closed financial year 2025 with a result of € 29,079 after tax. For that financial year HIBISCUS MED recorded a gross margin of € 57,781 and equity of € 39,079. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 23, 2026.
€ 39,079
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 29,079
Profit after tax over the fiscal year.
€ 42
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 29,079.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 30,687
Of which on lease € 30,687.
Debts at end 2025
€ 35,433
€ 9,090 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 43,116
Supplier invoices still open on the last day of the fiscal year.
€ 11,726
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Ask about HIBISCUS MED the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to HIBISCUS MED?
What happened at HIBISCUS MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 29,079. filed late Source: NBB ↗
- CYR-RUFIN DIKA SHELIJOU stepped down as director. NBB
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Asse. KBO
- MADJOU PAULINE became a director. NBB
- CYR-RUFIN DIKA SHELIJOU became a director. NBB
In short
Paid € 11,726 in corporate taxes since 2025.
Management
Behind HIBISCUS MED is MADJOU PAULINE.
Directors
According to the 2025 annual accounts
MADJOU PAULINE
Director
since 2024
CYR-RUFIN DIKA SHELIJOU
Director
since 2024 · until 2026
Establishments
Establishment units
Physical locations of this company
Stokstraat 33 box 2
9340 Lede
Brusselsesteenweg 18A
1730 Asse
Active since 17 December 2024
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Lede
Same main activity (Handelsbemiddeling in de niet-gespecialiseerde groothandel), 7 active companies in Lede, largest first.
€ 78,933 gross margin · 2025
€ 44,584 gross margin · 2025
€ 4,841 gross margin · 2025
€ 2,818 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- DIKA SHELIJOU Joseph(oprichter) 50%
- MADJOU Pauline(oprichter) 50%
Details
- Company number
- 1017.485.359
- VAT number
- BE 1017.485.359
- Registered office
- Stokstraat 33 bus 2, 9340 Lede
- Names & denominations
- HIBISCUS MED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 December 2024
- Peppol
- Not registered
- Activities · NACE
Handelsbemiddeling in de niet-gespecialiseerde groothandel
Activiteiten van verpleegkundigen en verloskundigen